Chemotherapy in combination with anti-PD-1 agents as adjuvant therapy for high-risk oral mucosal melanoma

被引：0
|
作者：
Yunteng Wu
Dongliang Wei
Guoxin Ren
Wei Guo
机构：
[1] Shanghai Ninth People’s Hospital,Department of Oral and Maxillofacial
[2] Shanghai Jiao Tong University School of Medicine,Head and Neck Oncology
[3] Shanghai Jiao Tong University,College of Stomatology
[4] National Center for Stomatology,undefined
[5] National Clinical Research Center for Oral Diseases,undefined
[6] Shanghai Key Laboratory of Stomatology,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Adjuvant therapy; Anti-programmed cell death 1 (anti-PD-1); Chemotherapy; High-dose interferon-α2b; High-risk oral mucosal melanoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2293 / 2300
页数：7
相关论文
共 50 条
  • [1] Chemotherapy in combination with anti-PD-1 agents as adjuvant therapy for high-risk oral mucosal melanoma
    Wu, Yunteng
    Wei, Dongliang
    Ren, Guoxin
    Guo, Wei
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2293 - 2300
  • [2] The case for adjuvant BRAF-targeted therapy versus adjuvant anti-PD-1 therapy for patients with resected, high-risk melanoma
    Mooradian, Meghan J. J.
    Sullivan, Ryan J. J.
    [J]. CANCER, 2023, 129 (14) : 2117 - 2121
  • [3] The Efficacy of Anti-PD-1 Agents in Acral and Mucosal Melanoma
    Shoushtari, Alexander N.
    Munhoz, Rodrigo R.
    Kuk, Deborah
    Ott, Patrick A.
    Johnson, Douglas B.
    Tsai, Katy K.
    Rapisuwon, Suthee
    Eroglu, Zeynep
    Sullivan, Ryan J.
    Luke, Jason J.
    Gangadhar, Tara C.
    Salama, April K. S.
    Clark, Varina
    Burias, Clare
    Puzanov, Igor
    Atkins, Michael B.
    Algazi, Alain P.
    Ribas, Antoni
    Wolchok, Jedd D.
    Postow, Michael A.
    [J]. CANCER, 2016, 122 (21) : 3354 - 3362
  • [4] TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy
    Eckardt, Julia
    Schroeder, Christopher
    Martus, Peter
    Armeanu-Ebinger, Sorin
    Kelemen, Olga
    Gschwind, Axel
    Bonzheim, Irina
    Eigentler, Thomas
    Amaral, Teresa
    Ossowski, Stephan
    Riess, Olaf
    Flatz, Lukas
    Garbe, Claus
    Forschner, Andrea
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (02) : 833 - 840
  • [5] Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma
    Patrinely, J. Randall, Jr.
    Johnson, Rebecca
    Lawless, Aleigha R.
    Bhave, Prachi
    Sawyers, Amelia
    Dimitrova, Maya
    Yeoh, Hui Ling
    Palmeri, Marisa
    Ye, Fei
    Fan, Run
    Davis, Elizabeth J.
    Rapisuwon, Suthee
    Long, Georgina V.
    Haydon, Andrew
    Osman, Iman
    Mehnert, Janice M.
    Carlino, Matteo S.
    Sullivan, Ryan J.
    Menzies, Alexander M.
    Johnson, Douglas B.
    [J]. JAMA ONCOLOGY, 2021, 7 (05) : 744 - 748
  • [6] TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy
    Julia Eckardt
    Christopher Schroeder
    Peter Martus
    Sorin Armeanu-Ebinger
    Olga Kelemen
    Axel Gschwind
    Irina Bonzheim
    Thomas Eigentler
    Teresa Amaral
    Stephan Ossowski
    Olaf Rieß
    Lukas Flatz
    Claus Garbe
    Andrea Forschner
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 833 - 840
  • [7] Safety and efficacy of adjuvant anti-PD1 therapy (nivolumab) in combination with vaccine in resected high-risk metastatic melanoma
    Gibney, Geoffrey Thomas
    Weber, Jeffrey S.
    Kudchadkar, Ragini Reiney
    De Conti, Ronald C.
    Tetteh, Leticia
    Eysmans, Cabell
    Yu, Bin
    Martinez, Alberto J.
    Younos, Ibrahim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] A MULTICENTER CHARACTERIZATION OF CHRONIC TOXICITIES FOLLOWING ADJUVANT ANTI-PD-1 THERAPY FOR HIGH RISK RESECTED MELANOMA
    Patrinely, James
    Johnson, Rebecca
    Lawless, Aleigha
    Bhave, Prachi
    Sawyers, Amelia
    Dimitrova, Maya
    Yeohc, Hui
    Palmeri, Marisa
    Davis, Elizabeth
    Rapisuwon, Suthee
    Long, Georgina
    Haydon, Andrew
    Osman, Iman
    Mehnert, Janice
    Carlino, Matteo
    Sullivan, Ryan
    Menzies, Alexander
    Johnson, Douglas
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A114 - A115
  • [9] Anti-PD-1 Therapy in Melanoma
    Moreno, Blanca Hornet
    Parisi, Giulia
    Robert, Lidia
    Ribas, Anton
    [J]. SEMINARS IN ONCOLOGY, 2015, 42 (03) : 466 - 473
  • [10] Temozolomide plus cisplatin versus toripalimab (anti-PD-1) as adjuvant therapy in resected mucosal melanoma.
    Lian, Bin
    Tian, Hui
    Si, Lu
    Chi, Zhihong
    Sheng, Xinan
    Wang, Xuan
    Mao, Lili
    Bai, Xue
    Tang, Bixia
    Yan, Xieqiao
    Li, Siming
    Zhou, Li
    Wei, Xiaoting
    Li, Juan
    Li, Caili
    Cui, Chuanliang
    Guo, Jun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345